These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 7386428)

  • 1. Measles-specific lymphocyte reactivity and serum antibody in subjects with different measles histories.
    Krause PJ; Cherry JD; Carney JM; Naiditch MJ; O'Connor K
    Am J Dis Child; 1980 Jun; 134(6):567-71. PubMed ID: 7386428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Revaccination of previous recipients of killed measles vaccine: clinical and immunologic studies.
    Krause PJ; Cherry JD; Naiditch MJ; Deseda-Tous J; Walbergh EJ
    J Pediatr; 1978 Oct; 93(4):565-71. PubMed ID: 702235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Persistence of measles antibody after revaccination.
    Markowitz LE; Albrecht P; Orenstein WA; Lett SM; Pugliese TJ; Farrell D
    J Infect Dis; 1992 Jul; 166(1):205-8. PubMed ID: 1607699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measles vaccine immunogenicity in 6- versus 15-month-old infants born to mothers in the measles vaccine era.
    Johnson CE; Nalin DR; Chui LW; Whitwell J; Marusyk RG; Kumar ML
    Pediatrics; 1994 Jun; 93(6 Pt 1):939-44. PubMed ID: 8190581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measles immunity after revaccination: results in children vaccinated before 10 months of age.
    Linnemann CC; Dine MS; Roselle GA; Askey PA
    Pediatrics; 1982 Mar; 69(3):332-5. PubMed ID: 7063289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular and humoral immune responses to measles in immune adults re-immunized with measles vaccine.
    Wong-Chew RM; Beeler JA; Audet S; Santos JI
    J Med Virol; 2003 Jun; 70(2):276-80. PubMed ID: 12696117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measles immunization status in 1972 among first- and second-grade school children in Danbury, Connecticut.
    Lepow ML; Steele FM; Ross MR; Randolph MF
    Pediatrics; 1975 Mar; 55(3):348-53. PubMed ID: 806881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Revaccination against measles--a pilot study.
    Watson GI; Nichols JA; Robshaw JR
    J R Coll Gen Pract; 1975 Dec; 25(161):863-73. PubMed ID: 1223275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The results of multiyear observations on the duration of the maintenance of immunity in those vaccinated and revaccinated against and recovered from measles].
    Sliusar' LI; Sokhin AA; Radomskaia FS; Degtiareva GV; Panasenko LI; Litvinova TP; Komarevskaia RV; Bol'shinskaia ZhI
    Zh Mikrobiol Epidemiol Immunobiol; 1990 Aug; (8):66-70. PubMed ID: 2239007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Haemagglutination inhibition antibody levels one year after natural measles infection and vaccination.
    Eghafona NO; Ahmad AA; Ezeokoli CD; Emejuaiwe SO
    Microbios; 1991; 67(274):33-6. PubMed ID: 1758308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Persistence of vaccine-induced antibody to measles 26-33 years after vaccination.
    Dine MS; Hutchins SS; Thomas A; Williams I; Bellini WJ; Redd SC
    J Infect Dis; 2004 May; 189 Suppl 1():S123-30. PubMed ID: 15106101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Further-attenuated measles vaccine: characteristics and use.
    Krugman S
    Rev Infect Dis; 1983; 5(3):477-81. PubMed ID: 6879002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Need for measles revaccination in adolescents: correlation with birth date prior to 1972.
    Yeager AS; Harvey B; Crosson FJ; Davis JH; Ross LA; Halonen PE
    J Pediatr; 1983 Feb; 102(2):191-5. PubMed ID: 6822921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Booster vaccination with further live attenuated measles vaccine.
    Bass JW; Halstead SB; Fischer GW; Podgore JK; Pearl WR; Schydlower M; Wiebe RA; Ching FM
    JAMA; 1976 Jan; 235(1):31-4. PubMed ID: 945997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Intranasal revaccination of children with live measles vaccine: development of local immunity].
    Liashenko VA; Iuminova NV; Krasnova VP; Glazkova NV; Svirina VS
    Vopr Virusol; 1999; 44(3):124-6. PubMed ID: 10392436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Response to measles revaccination among Bolivian school-aged children.
    Bartoloni A; Cutts FT; Guglielmetti P; Brown D; Bianchi Bandinelli ML; Hurtado H; Roselli M
    Trans R Soc Trop Med Hyg; 1997; 91(6):716-8. PubMed ID: 9509188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measles vaccine failures: lack of sustained measles-specific immunoglobulin G responses in revaccinated adolescents and young adults.
    Cohn ML; Robinson ED; Faerber M; Thomas D; Geyer S; Peters S; Martin M; Martin A; Sobel D; Jones R
    Pediatr Infect Dis J; 1994 Jan; 13(1):34-8. PubMed ID: 8170730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ineffectiveness of historical data in predicting measles susceptibility.
    Scott RM; Butler AB; Schydlower M; Rawlings P
    Pediatrics; 1984 Jun; 73(6):777-80. PubMed ID: 6728580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular immunity in measles vaccine failure: demonstration of measles antigen-specific lymphoproliferative responses despite limited serum antibody production after revaccination.
    Ward BJ; Boulianne N; Ratnam S; Guiot MC; Couillard M; De Serres G
    J Infect Dis; 1995 Dec; 172(6):1591-5. PubMed ID: 7594723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The critical titer of hemagglutination inhibiting (HAI) antibody in measles infection].
    Xu FG
    Zhonghua Liu Xing Bing Xue Za Zhi; 1983 Apr; 4(2):83-8. PubMed ID: 6883489
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.